Stockscreener 앱 받기
35.39
1.69%
-0.61
시장 영업 전:
36.08
0.69
+1.95%
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Apogee Therapeutics provides pipeline progress and reports second quarter 2025 financial results - MarketScreener
Apogee Therapeutics, Inc. SEC 10-Q Report - TradingView
Apogee Therapeutics Q2 Net Loss Widens - MarketScreener
Apogee Therapeutics Q2 2025 Financial Results and Pipeline Progress - TradingView
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results - GlobeNewswire
Breakthrough: Apogee's New Atopic Dermatitis Drug Achieves 71% Efficacy with 6-Month Dosing Potential - Stock Titan
Apogee Therapeutics APGE Q2 2025 Earnings Preview Upside Potential Hinges on Strategic Partnerships - AInvest
Apogee Therapeutics CMO Carl Dambkowski Sells Shares - TradingView
This Apogee Therapeutics Insider Increased Their Holding In The Last Year - 富途牛牛
Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High? - Yahoo Finance
What are the latest earnings results for Apogee Therapeutics Inc.Outstanding capital returns - Jammu Links News
When is Apogee Therapeutics Inc. stock expected to show significant growthDouble or triple returns - Jammu Links News
Is Apogee Therapeutics Inc. a growth stock or a value stockFastest-growing stock picks - Jammu Links News
What is the risk reward ratio of investing in Apogee Therapeutics Inc. stockAchieve consistent profits with proven methods - Jammu Links News
How many analysts rate Apogee Therapeutics Inc. as a “Buy”Maximize your returns with expert insights - Jammu Links News
Is Apogee Therapeutics Inc. a good long term investmentInvest smarter with expert stock picks - Jammu Links News
Should I hold or sell Apogee Therapeutics Inc. stock in 2025Free Stock Selection - Jammu Links News
Is it the right time to buy Apogee Therapeutics Inc. stockAchieve consistent double-digit growth rates - Jammu Links News
Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug - MSN
How volatile is Apogee Therapeutics Inc. stock compared to the marketChart Pattern Updates For Fast Growth - Jammu Links News
What’s next for Apogee Therapeutics Inc. stock priceTop Performing Stock Insights Released Daily - metal.it
11 Best Future Stocks to Buy Now - Insider Monkey
Published on: 2025-07-30 23:15:33 - metal.it
Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma - MSN
Earnings visualization tools for Apogee Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
Multi Factor Analysis Ranks Apogee Therapeutics Inc. as Strong BuyIntraday Trend Analysis for Fast Gains Released - metal.it
Order Book Volume Tilts Bullish on Apogee Therapeutics Inc.Trade Ready Stock Watch for Short Term Published - metal.it
Is Apogee Therapeutics Inc. stock overvalued or undervaluedFind the best stocks for sustainable growth - Jammu Links News
What makes Apogee Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser
Intrinsic Value of Apogee Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Elite Traders Group - Newser
What analysts say about Apogee Therapeutics Inc. stockOver 200% growth - PrintWeekIndia
What drives Apogee Therapeutics Inc. stock priceDynamic growth stocks - Autocar Professional
Apogee Therapeutics Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
What makes Apogee Therapeutics Inc. stock attractive to long term investorsDynamic growth stocks - Jammu Links News
InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics By Investing.com - Investing.com Canada
Teacher Retirement System of Texas Sells 629 Shares of Apogee Therapeutics Inc. (NASDAQ:APGE) - Defense World
BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - MSN
0.24%
3.39%
자본화:
|
볼륨(24시간):